Details of the Drug Reposition

General Information of This Drug (ID: DMGB32Z)

Drug Name	PF-06427878 DMGB32Z

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Hyperlipidaemia	DIS4R2OG	5C80	Phase 1	[1]
Cardiovascular disease	DIS2IQDX	BA00-BE2Z	Phase 1	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02208284) A Single Oral Dose Study Of PF-06427878 In Healthy Adult Subjects. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)